Infliximab-Induced Lupus-Like Syndrome in a Female Patient With Rheumatoid Arthritis (A Case Report): An Accident or Regularity?

Муравьев, Ю. В.; Lebedeva, V.; Аламанкина, С. Ю.

doi:10.14412/1995-4484-2017-446-448

Naučno-praktičeskaâ revmatologiâ

2017

DOI: 10.14412/1995-4484-2017-446-448

|View full text |Cite

Infliximab-Induced Lupus-Like Syndrome in a Female Patient With Rheumatoid Arthritis (A Case Report): An Accident or Regularity?

Ю. В. Муравьев¹,

V. Lebedeva²,

С. Ю. Аламанкина³

Abstract: The paper describes a case of infliximab-induced lupus-like syndrome in a female patient with rheumatoid arthritis and discusses the possible causes of this pathology.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2018

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 36 publications

(43 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

Drug-induced lupus

Клюквина¹,

Гунчикова

Aa³

2018

Sovremennaâ revmatologiâ

View full text Add to dashboard Cite

Drug-induced lupus (DIL) is an autoimmune phenomenon that has similar clinical and laboratory manifestations with idiopathic systemic lupus erythematosus (SLE). About 100 drugs are now known to be associated with the development of DIL. Its diagnosis is verified in the presence of a chronological relationship between the long-term administration of drugs and the mandatory presence of one clinical and one laboratory diagnostic criteria for SLE.The paper deals with the etiology, pathogenesis, and differential diagnosis of DIL. It presents a spectrum of drugs that can cause DIL and considers the features of its different forms.Based on the recent data available in the literature, the authors analyze the occurrence of autoimmune responses due to the useof biologic agents (BAs), primarily tumor necrosis factor-αinhibitors. Therapeutic approaches for DIL are discussed. Recommendations are given for screening the patients in the use of BAs. Clinical examples are provided.

show abstract

Drug-induced lupus

Клюквина¹,

Гунчикова

Aa³

2018

Sovremennaâ revmatologiâ

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Infliximab-Induced Lupus-Like Syndrome in a Female Patient With Rheumatoid Arthritis (A Case Report): An Accident or Regularity?

Abstract: The paper describes a case of infliximab-induced lupus-like syndrome in a female patient with rheumatoid arthritis and discusses the possible causes of this pathology.

Cited by 1 publication

References 36 publications

Drug-induced lupus

Drug-induced lupus

Contact Info

Product

Resources

About